Arbonne Intelligence Pollution Defense Spf30 Cc Cream - Medium Shade
Spf30 Cc Cream - Medium Shade
Arbonne International, Llc
Human Otc Drug
NDC 42508-222Arbonne Intelligence Pollution Defense Spf30 Cc Cream - Medium Shade also known as Spf30 Cc Cream - Medium Shade is a human otc drug labeled by 'Arbonne International, Llc'. National Drug Code (NDC) number for Arbonne Intelligence Pollution Defense Spf30 Cc Cream - Medium Shade is 42508-222. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Arbonne Intelligence Pollution Defense Spf30 Cc Cream - Medium Shade drug includes Titanium Dioxide - 2.5 mg/100mg Zinc Oxide - 7.2 mg/100mg . The currest status of Arbonne Intelligence Pollution Defense Spf30 Cc Cream - Medium Shade drug is Active.
Drug Information:
| Drug NDC: | 42508-222 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Arbonne Intelligence Pollution Defense Spf30 Cc Cream - Medium Shade |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Spf30 Cc Cream - Medium Shade |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Arbonne International, Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | TITANIUM DIOXIDE - 2.5 mg/100mg
ZINC OXIDE - 7.2 mg/100mg
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Sep, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 15 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Arbonne International, LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 15FIX9V2JP
SOI2LOH54Z
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 42508-222-18 | 1 TUBE in 1 CARTON (42508-222-18) / 34000 mg in 1 TUBE | 01 Sep, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose sunscreen
Product Elements:
Arbonne intelligence pollution defense spf30 cc cream - medium shade spf30 cc cream - medium shade aluminum oxide phenoxyethanol shea butter magnesium stearate isopropyl titanium triisostearate isononyl isononanoate medium-chain triglycerides diisopropyl sebacate ethylhexyl palmitate polymethylsilsesquioxane (4.5 microns) glycerin argan oil tocopherol isopropyl myristate silicon dioxide water dimethicone polyglyceryl-2 monoisostearate polysilicone-15 polyhydroxystearic acid (2300 mw) disteardimonium hectorite castor oil sodium chloride ferric oxide red mica ferrosoferric oxide stearalkonium hectorite octyldodecyl myristate taraxacum officinale root medicago sativa leaf chicory root ethylhexylglycerin ferric oxide yellow levomenol aloe vera leaf cyclomethicone 5 propylene carbonate farnesol cyclomethicone 4 biosaccharide gum-4 capparis spinosa whole titanium dioxide titanium dioxide zinc oxide zinc oxide
Indications and Usage:
Directions for sunscreen use: apply liberally and evenly 15 minutes before sun exposure reapply at least every 2 hours use a water-resistant sunscreen if swimming or sweating children under 6 months of age: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad specrum spf value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m.-2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses
Warnings:
Warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove. stop use and ask a doctor if rash occurs
Dosage and Administration:
Uses helps prevent sunburn if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Package Label Principal Display Panel:
Package, label, principal display panel r02_01_ai_pollutiondefensecccreamspf30_comp_fpo.jpg r02_01_ai_pollutiondefensecccreamspf30_ctn_fpo.jpg r04_z1-2-3_pollutiondefense_cccream_unitlbl_fpo.jpg shade carton primary
Further Questions:
Questions or comments? 1.800.272.6663 monday-friday 6 a.m.-6 p.m. pst